AI in Nuclear Medicine: Improvements in the Field
Chi Liu, PhD
PeerJohn Barbieri, MD, MBA, FAAD
PeerEffects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
James Januzzi, MD
PeerMartin Maron, MD
PeerDavid J. Maron, MD
PeerMarc P. Bonaca, MD, MPH
PeerDeepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
PeerMatthew Jay Budoff, MD
PeerDeep Learner: Building AI to Improve Cardiovascular Care
Pierre Elias, MD
PeerAgainst the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Christopher Petit, MD
PeerConfronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Michael Bloch, MD
PeerConversations With Cardiologists: Clinical Perspectives on the Treatment of HFmrEF and HFpEF
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy